JB Chemicals Reports 22% Profit Growth in Q3; Stock Rises Over 1%

JB Chemicals Pharmaceuticals reported a 21.79% rise in consolidated net profit to Rs 197.89 crore for Q3 FY26, supported by a 10.51% increase in revenue to Rs 1,064.72 crore. Profit before tax grew 22.42% to Rs 266.87 crore, with operating EBITDA up 12.96% to Rs 305 crore and margins improving slightly. The company’s stock rose over 1% amid a three-day gain streak, outperforming the Nifty Pharma index and maintaining a price-to-earnings ratio of 42.28 based on trailing earnings.